UBS Group AG - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 74 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$6,232
+211.6%
16,844
+342.2%
0.00%
Q3 2022$2,0000.0%3,809
-1.4%
0.00%
Q2 2022$2,000
-71.4%
3,862
-56.4%
0.00%
Q1 2022$7,000
-93.3%
8,862
-88.7%
0.00%
Q4 2021$104,000
+235.5%
78,540
+474.5%
0.00%
Q3 2021$31,000
-86.5%
13,671
-73.8%
0.00%
Q2 2021$229,000
-70.9%
52,106
-51.9%
0.00%
Q1 2021$786,000
+2811.1%
108,325
+1639.6%
0.00%
Q4 2020$27,000
+68.8%
6,227
+62.2%
0.00%
Q3 2020$16,000
-30.4%
3,840
+0.4%
0.00%
Q2 2020$23,000
-20.7%
3,823
+0.4%
0.00%
Q1 2020$29,000
-49.1%
3,809
-8.9%
0.00%
Q4 2019$57,000
+14.0%
4,179
-1.0%
0.00%
Q3 2019$50,000
-10.7%
4,223
+5.9%
0.00%
Q2 2019$56,000
+522.2%
3,988
+661.1%
0.00%
Q1 2019$9,000
-52.6%
524
-57.7%
0.00%
Q4 2018$19,0001,2390.00%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ORCHARD THERAPEUTICS PLC shareholders